Jocelyn Aw serves as the Finance Director for Acquisition & Divestiture Operations at Johnson & Johnson, where she leverages her extensive 17 years of experience in consulting and multi-business finance leadership to drive strategic growth across the Asia Pacific region. In her current role, Jocelyn...
Jocelyn Aw serves as the Finance Director for Acquisition & Divestiture Operations at Johnson & Johnson, where she leverages her extensive 17 years of experience in consulting and multi-business finance leadership to drive strategic growth across the Asia Pacific region. In her current role, Jocelyn is pivotal in executing complex acquisition and divestiture deals that span diverse sectors, including pharmaceuticals, medical devices, and fast-moving consumer goods (FMCG). Her expertise encompasses critical therapeutic areas such as Oncology, Immunology, and Neuroscience, as well as essential medical device categories like surgical tools and diabetes care.
Jocelyn's finance partnering approach is instrumental in aligning financial insights with the strategic objectives of Sales and Marketing leaders. By facilitating data-driven commercial decision-making processes, she ensures that the execution of business strategies is tracked and optimized for maximum impact. Her proficiency in financial modeling and budget management allows her to provide actionable insights that support the company's growth ambitions while enhancing operational efficiency.
In addition to her technical skills, Jocelyn excels in people management and enabling change, fostering a culture of collaboration and innovation within her teams. Her strategic planning capabilities are complemented by a deep understanding of marketing strategy, making her a key player in navigating the complexities of the healthcare landscape. As she continues to lead high-stakes projects at Johnson & Johnson, Jocelyn remains committed to driving sustainable growth and delivering value across the Asia Pacific region.
